Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Curis (CRIS) EBITDA (2016 - 2026)

Curis filings provide 16 years of EBITDA readings, the most recent being $19.4 million for Q4 2025.

  • On a quarterly basis, EBITDA rose 301.25% to $19.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$7.6 million, a 82.62% increase, with the full-year FY2025 number at -$7.6 million, up 82.62% from a year prior.
  • EBITDA hit $19.4 million in Q4 2025 for Curis, up from -$7.7 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $19.4 million in Q4 2025 to a low of -$16.5 million in Q1 2022.
  • Median EBITDA over the past 5 years was -$11.2 million (2021), compared with a mean of -$10.0 million.
  • Biggest five-year swings in EBITDA: plummeted 84.98% in 2021 and later skyrocketed 301.25% in 2025.
  • Curis' EBITDA stood at -$13.7 million in 2021, then grew by 19.6% to -$11.0 million in 2022, then decreased by 4.98% to -$11.6 million in 2023, then grew by 16.99% to -$9.6 million in 2024, then skyrocketed by 301.25% to $19.4 million in 2025.
  • The last three reported values for EBITDA were $19.4 million (Q4 2025), -$7.7 million (Q3 2025), and -$8.6 million (Q2 2025) per Business Quant data.